Effects of pharmaceuticals and other active chemicals at biological targets: mechanisms, interactions, and integration into PB-PK/PD models
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of pharmaceuticals and other active chemicals at biological targets: mechanisms, interactions, and integration into PB-PK/PD models
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 13, Issue 7, Pages 867-887
Publisher
Informa Healthcare
Online
2009-06-17
DOI
10.1517/14728220903018965
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Receptor Occupancy and Brain Free Fraction
- (2009) J. Watson et al. DRUG METABOLISM AND DISPOSITION
- Inhibition and induction of human cytochrome P450 enzymes: current status
- (2008) Olavi Pelkonen et al. ARCHIVES OF TOXICOLOGY
- Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the In vivo Elimination of Methotrexate and its Main Toxic Metabolite 7-hydroxymethotrexate
- (2008) M. L.H. Vlaming et al. CLINICAL CANCER RESEARCH
- Local Kinetics and Dynamics of Xenobiotics
- (2008) Olavi Pelkonen et al. CRITICAL REVIEWS IN TOXICOLOGY
- PK/PD modelling and simulations: utility in drug development
- (2008) Iris Rajman DRUG DISCOVERY TODAY
- Functional Consequences of Active Hepatic Uptake on Cytochrome P450 Inhibition in Rat and Human Hepatocytes
- (2008) K. Grime et al. DRUG METABOLISM AND DISPOSITION
- Prediction of the Pharmacokinetics of Atorvastatin, Cerivastatin, and Indomethacin Using Kinetic Models Applied to Isolated Rat Hepatocytes
- (2008) S. W. Paine et al. DRUG METABOLISM AND DISPOSITION
- Impact of Genetic Polymorphisms of Transporters on the Pharmacokinetic, Pharmacodynamic and Toxicological Properties of Anionic Drugs
- (2008) Kazuya Maeda et al. Drug Metabolism and Pharmacokinetics
- The Roles of Nuclear Receptors CAR and PXR in Hepatic Energy Metabolism
- (2008) Yoshihiro Konno et al. Drug Metabolism and Pharmacokinetics
- Biomonitoring of Perfluorinated Compounds in Children and Adults Exposed to Perfluorooctanoate-Contaminated Drinking Water
- (2008) Jürgen Hölzer et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Prenatal Exposure to Perfluorooctanoate (PFOA) and Perfluorooctanesulfonate (PFOS) and Maternally Reported Developmental Milestones in Infancy
- (2008) Chunyuan Fei et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Integrating systems approaches into pharmaceutical sciences
- (2008) Hans V. Westerhoff et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Noveld-Xylose Derivatives Stimulate Muscle Glucose Uptake by Activating AMP-Activated Protein Kinase α
- (2008) Arie Gruzman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Physiologically Based Pharmacokinetic Modeling to Predict Transporter-Mediated Clearance and Distribution of Pravastatin in Humans
- (2008) T. Watanabe et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Toxicogenomic Dissection of the Perfluorooctanoic Acid Transcript Profile in Mouse Liver: Evidence for the Involvement of Nuclear Receptors PPARα and CAR
- (2008) Mitchell B. Rosen et al. TOXICOLOGICAL SCIENCES
- ABCG2/BCRP decreases the transfer of a food-born chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in perfused term human placenta
- (2008) Päivi Myllynen et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The Tangle of Nuclear Receptors that Controls Xenobiotic Metabolism and Transport: Crosstalk and Consequences
- (2007) Jean-Marc Pascussi et al. Annual Review of Pharmacology and Toxicology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started